Literature DB >> 18650552

Clarithromycin transport by gingival fibroblasts and epithelial cells.

C-H Chou1, J D Walters.   

Abstract

Macrolide antibiotics penetrate cells, but the mechanism by which this occurs is unclear. The objective of this study was to characterize the mechanisms of clarithromycin uptake by gingival fibroblasts and oral epithelium. Cultured human gingival fibroblasts and SCC-25 cells were incubated with [(3)H]-clarithromycin. We assayed clarithromycin transport by measuring cell-associated radioactivity over time. Fibroblasts and epithelial cells rapidly accumulated clarithromycin, attaining steady-state intracellular concentrations within 15 minutes. Incubation in medium containing 2 mug/mL clarithromycin yielded steady-state intracellular concentrations of 75.8 mug/mL in fibroblasts and 6.6 mug/mL in SCC-25 cells. Clarithromycin transport exhibited Michaelis-Menten kinetics and was inhibited below 37 degrees C. The Michaelis constants for fibro-blasts and SCC-25 cells were 78.4 and 227 mug/mL, respectively, while the maximum transport velocities were 264 and 381 ng/min/10(6) cells, respectively. Thus, both types of cells take up clarithromycin via a concentrative active transport system. By increasing intracellular clarithromycin levels, this system may enhance the effectiveness of clarithromycin against invasive periodontal pathogens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18650552      PMCID: PMC2493570          DOI: 10.1177/154405910808700812

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  32 in total

1.  The presence of bacteria in the oral epithelium in periodontal disease. II. Immunohistochemical identification of bacteria.

Authors:  F R Saglie; C T Smith; M G Newman; F A Carranza; J H Pertuiset; L Cheng; E Auil; R J Nisengard
Journal:  J Periodontol       Date:  1986-08       Impact factor: 6.993

2.  A double-blind placebo-controlled trial of azithromycin as an adjunct to non-surgical treatment of periodontitis in adults: clinical results.

Authors:  S R Smith; D M Foyle; J Daniels; S Joyston-Bechal; F C Smales; A Sefton; J Williams
Journal:  J Clin Periodontol       Date:  2002-01       Impact factor: 8.728

3.  Mechanisms of fluoroquinolone transport by human neutrophils.

Authors:  J D Walters; F Zhang; R J Nakkula
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

4.  Dual individualization: antibiotic dosage calculation from the integration of in-vitro pharmacodynamics and in-vivo pharmacokinetics.

Authors:  J J Schentag; D J Swanson; I L Smith
Journal:  J Antimicrob Chemother       Date:  1985-01       Impact factor: 5.790

5.  Effects of eight antibacterial agents on cell survival and expression of epithelial-cell- or cell-adhesion-related genes in human gingival epithelial cells.

Authors:  Kiichiro Inoue; Shin-Ichi Kumakura; Minoru Uchida; Takeki Tsutsui
Journal:  J Periodontal Res       Date:  2004-02       Impact factor: 4.419

6.  Quantitative comparison of the cytocidal effect of seven macrolide antibiotics on human periodontal ligament fibroblasts.

Authors:  Noriko Maizumi; Yukiko Tamura; Hideaki Kanai; Takeki Tsutsui
Journal:  J Periodontal Res       Date:  2002-08       Impact factor: 4.419

Review 7.  Systemic anti-infective periodontal therapy. A systematic review.

Authors:  Anne D Haffajee; Sigmund S Socransky; John C Gunsolley
Journal:  Ann Periodontol       Date:  2003-12

8.  The capability of Actinobacillus actinomycetemcomitans, Bacteroides gingivalis and Bacteroides intermedius to indicate progressive periodontitis; a retrospective study.

Authors:  L Bragd; G Dahlén; M Wikström; J Slots
Journal:  J Clin Periodontol       Date:  1987-02       Impact factor: 8.728

9.  Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultured from human squamous cell carcinomas.

Authors:  J G Rheinwald; M A Beckett
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

10.  Distribution of systemic clarithromycin to gingiva.

Authors:  Renita C Burrell; John D Walters
Journal:  J Periodontol       Date:  2008-09       Impact factor: 6.993

View more
  10 in total

1.  Azithromycin kills invasive Aggregatibacter actinomycetemcomitans in gingival epithelial cells.

Authors:  Pin-Chuang Lai; John D Walters
Journal:  Antimicrob Agents Chemother       Date:  2012-12-28       Impact factor: 5.191

2.  Azithromycin concentrations in blood and gingival crevicular fluid after systemic administration.

Authors:  Pin-Chuang Lai; Weiting Ho; Nidhi Jain; John D Walters
Journal:  J Periodontol       Date:  2011-03-21       Impact factor: 6.993

3.  [Efficacy of clarithromycin in the adjuvant treatment of chronic periodontitis: a Meta-analysis].

Authors:  Yin Bai; Yuan-Liang Bai; Jing Lai; Jiao Huang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2020-06-01

4.  Azithromycin decreases crevicular fluid volume and mediator content.

Authors:  W Ho; T Eubank; B Leblebicioglu; C Marsh; J Walters
Journal:  J Dent Res       Date:  2010-04-16       Impact factor: 6.116

5.  Clarithromycin accumulation by phagocytes and its effect on killing of Aggregatibacter actinomycetemcomitans.

Authors:  Irma Iskandar; John D Walters
Journal:  J Periodontol       Date:  2010-10-08       Impact factor: 6.993

6.  Effect of gingivitis on azithromycin concentrations in gingival crevicular fluid.

Authors:  Nidhi Jain; Pin-Chuang Lai; John D Walters
Journal:  J Periodontol       Date:  2012-02-14       Impact factor: 6.993

7.  Azithromycin suppresses P. gingivalis LPS-induced pro-inflammatory cytokine and chemokine production by human gingival fibroblasts in vitro.

Authors:  C J Doyle; T R Fitzsimmons; C Marchant; A A S S K Dharmapatni; R Hirsch; P M Bartold
Journal:  Clin Oral Investig       Date:  2014-05-08       Impact factor: 3.573

8.  Distribution of systemic clarithromycin to gingiva.

Authors:  Renita C Burrell; John D Walters
Journal:  J Periodontol       Date:  2008-09       Impact factor: 6.993

9.  Effectiveness of antibacterial agents against cell-invading bacteria such as Streptococcus pyogenes and Haemophilus influenzae.

Authors:  Hiroyuki Iuchi; Junichiro Ohori; Satoshi Kiyama; Naoko Imuta; Junichiro Nishi; Yuichi Kurono; Masaru Yamashita
Journal:  BMC Microbiol       Date:  2021-05-14       Impact factor: 3.605

10.  Evaluating the effectiveness of clarithromycin as an adjunct to scaling and root planing: A randomized clinical trial.

Authors:  Jammula Suryaprasanna; Potini Lakshmi Radhika; Parupalli Karunakar; Koduganti Rekharani; Umrana Faizuddin; Mallela George Manojkumar; Suribabu Jammula
Journal:  J Indian Soc Periodontol       Date:  2018 Nov-Dec
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.